MHRA to Use Genetic Screening to Investigate Bleeds Caused by Blood Thinners

Published on February 15, 2024

Drugs to thin the blood are to be investigated by the Medicines and Healthcare Regulatory Agency (MHRA) as part of a collaboration with Genomics England for individualised medicine to see if some patients are more at risk from side effects than others. Known as direct anti-coagulants, the group of drugs will be examined by the pilot scheme known as the Yellow Card Biobank, which will run alongside the existing scheme to report all drug side effects and which has come under fierce criticism for failing patients. Around 1.5 million people in the UK are currently prescribed the anti-coagulants rivaroxaban, dabigatran, apixaban, and edoxaban, which have largely replaced the drug warfarin and are most commonly prescribed to those at risk of a stroke or with an abnormal heartbeat....

Continue reading on website
Other news

Spending Hundreds of Millions to Make a 0.1 Percent Different to the Great Barrier Reef

February 15, 2024
CommentaryAustralia’s federal government has thrown the barramundi fishing industry to the sharks as part of the blackmail payout to UNESCO to stop the organisation listing the Great Barrier Reef as “endangered.” However, UNESCO will be back in a few years for another payout—that’s what blackmailers do.Hard-working Aussie fishermen, and all the people who depend on them, are about to suffer severe

Man Accused of Killing Deputy Makes First Court Appearance

February 15, 2024
MARYVILLE, Tenn.—The man accused of killing a Tennessee deputy and wounding another during a traffic stop last week made his first court appearance Thursday.Kenneth Wayne DeHart Jr., 42, was arraigned but has not yet entered a plea on charges of first-degree murder, attempted first-degree murder, and being a felon in possession of a weapon, news outlets reported.Blount Sessions Court Judge William